Ho-Jae Han received Bachelor's degree from Dankook University, South Korea, in 2017. He has focused on understanding the genetic and molecular mechanisms that can overcome drug resistance in CML patients, and discovering novel molecular pathways that can enhance the effectiveness of targeted therapy. His research interests include human genetics in cancer.